Retatrutide is a novel, multi-receptor agonist that simultaneously targets the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-agonist profile makes it a highly advanced compound for studying complex metabolic pathways and systemic energy regulation.

Unlike single- or dual-pathway compounds, Retatrutide enables researchers to explore the interaction between incretin signaling and glucagon-mediated energy expenditure within a single model. This expanded mechanism of action has made it a focal point in emerging metabolic research, particularly in studies involving adipose tissue signaling, appetite regulation pathways, and overall metabolic efficiency.

Retatrutide is commonly utilized in research environments focused on understanding how multiple hormonal pathways coordinate to regulate body composition, energy balance, and nutrient utilization.

Mechanism of Action
Retatrutide acts through three primary receptor pathways:

• GLP-1 receptor activation: Associated with appetite signaling, gastric regulation, and glucose metabolism
• GIP receptor activation: Plays a role in insulin response and nutrient partitioning
• Glucagon receptor activation: Linked to increased energy expenditure and lipid metabolism

The combination of these three pathways allows for comprehensive investigation into metabolic regulation at both central and peripheral levels.

Key Research Applications

• Multi-pathway metabolic signaling studies
• Energy expenditure and thermogenesis research
• Appetite regulation and satiety pathway modeling
• Adipose tissue signaling and lipid metabolism
• Nutrient partitioning and metabolic efficiency.

Product Specifications

• Quantity: 20mg
• Form: Lyophilized powder
• Purity: ≥99% (HPLC tested)
• Appearance: White to off-white powder

Storage:

• Long-term: -20°C
• Short-term (reconstituted): 2–8°C

Reconstitution Guidance (General Laboratory Use)

• Retatrutide is supplied in lyophilized form and must be reconstituted prior to use in a controlled laboratory setting.
• Use sterile bacteriostatic water for reconstitution
• Introduce solution slowly along the vial wall to preserve peptide integrity
• Gently swirl—do not shake
• Exact concentrations and protocols should be determined based on specific research requirements.

Quality Assurance

• Third-party tested for purity and identity
• Batch-specific Certificate of Analysis (COA) available
• Produced by qualified manufacturing partners in controlled laboratory environments

What’s Included

• 1 × 20mg Retatrutide lyophilized vial
• COA access for batch verification

Research Use Disclaimer
For research use only. Not intended for human consumption.